Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

OBJECTIVES: Many vaccines require higher/additional doses or adjuvants to provide adequate protection for people with HIV (PWH). Here, we compare coronavirus disease 2019 (COVID-19) vaccine-induced antibody neutralization capacity in PWH vs. HIV-negative individuals following two vaccine doses. DESI...

Descripción completa

Detalles Bibliográficos
Autores principales: Costiniuk, Cecilia T., Singer, Joel, Lee, Terry, Galipeau, Yannick, McCluskie, Pauline S., Arnold, Corey, Langlois, Marc-André, Needham, Judy, Jenabian, Mohammad-Ali, Burchell, Ann N., Samji, Hasina, Chambers, Catharine, Walmsley, Sharon, Ostrowski, Mario, Kovacs, Colin, Tan, Darrell H.S., Harris, Marianne, Hull, Mark, Brumme, Zabrina L., Lapointe, Hope R., Brockman, Mark A., Margolese, Shari, Mandarino, Enrico, Samarani, Suzanne, Vulesevic, Branka, Lebouché, Bertrand, Angel, Jonathan B., Routy, Jean-Pierre, Cooper, Curtis L., Anis, Aslam H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Fast Track
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481923/
https://www.ncbi.nlm.nih.gov/pubmed/37534695
http://dx.doi.org/10.1097/QAD.0000000000003680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481923/
https://www.ncbi.nlm.nih.gov/pubmed/37534695
http://dx.doi.org/10.1097/QAD.0000000000003680

Ejemplares similares